68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik Giesel, Uwe Haberkorn, Thomas A. Hope, Klaus Kopka, Bernd J. Krause, Felix M. Mottaghy, Heiko Schoder, John Sunderland, Simon Wan, Hans-Juergen Wester, Stefano Fanti, Ken Herrmann*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

389 Citations (Web of Science)

Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation and reporting of Ga-68-PSMA PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of Ga-68-PSMA PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

Original languageEnglish
Pages (from-to)1014-1024
Number of pages11
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • PSMA
  • PET
  • Prostate cancer
  • Staging
  • Restaging
  • Guideline
  • MEMBRANE ANTIGEN-EXPRESSION
  • TUMOR-ASSOCIATED NEOVASCULATURE
  • GA-68-LABELED PSMA LIGAND
  • RENAL-CELL CARCINOMA
  • RADIATION-DOSIMETRY
  • RADIOLIGAND THERAPY
  • HBED-CC
  • ANDROGEN RECEPTOR
  • BIODISTRIBUTION
  • INHIBITOR

Cite this